Orbital fractures pose a significant concern in professional sports due to their potential effects on vision and extended recovery times. This study aimed to characterize the common mechanisms of orbital fractures among professional athletes and evaluate the average time needed to resume sports. Utilizing a comprehensive online injury database (www.ProSportsTransactions.com), this retrospective study identified all fractures to the orbital bones among Major League Baseball (MLB), National Football League (NFL), National Hockey League (NHL), and National Basketball Association (NBA) athletes between January 2000 and July 2022. The interval between orbital fracture and return to play was defined as return to sport. These timelines and injury causes were corroborated using publicly available reports and press releases. Athletes who did not return were excluded from the calculation. A total of 29 cases were identified: MLB (11), NBA (8), NHL (6), and NFL (4). Two injuries (7%) ended careers, whereas 8 (28%) ended the season. Among the 27 players who returned to sport, the average number of days absent was 92.5 (range: 1–315). The causes of orbital fractures included collisions with another player [12 (41%)], ball/puck [11 (38%)], punches [4 (14%)], and hockey stick [2 (7%)]. Most professional athletes who experienced orbital fractures returned to play in the same season. Return to sport varied widely depending on the severity of the injury and was often influenced by vision-specific sequelae. Further investigation is necessary to determine additional factors that may assist in accurately predicting return to sport among athletes with orbital fractures.
Background: Sepsis is a leading cause of pediatric mortality worldwide, disproportionately affecting children in low- and middle-income countries (LMICs). However, timely recognition of potential sepsis and access to healthcare resources needed to diagnose pediatric sepsis according to international guidelines are challenging in LMICs. This exploratory study aimed to develop machine learning (ML) models to detect pediatric sepsis and septic shock using a simplified set of clinical data contextualized for practical use in resource-limited settings. Methods: This was a secondary analysis of an observational study of 100 children with potential sepsis admitted to a non-profit referral hospital in Dhaka, Bangladesh. The outcomes were sepsis as defined by a Phoenix Sepsis Score (PSS) ≥ 2 and septic shock (sepsis plus PSS cardiovascular sub-score ≥ 1). Models were trained using either clinical + laboratory variables or clinical-only variables. A single 24 h worst-value assessment window was derived per patient; stratified 5-fold cross-validation was used to maintain class proportions across the training and test folds. Model performance was assessed using area under the precision–recall curve (AUPRC) and area under the receiver operating characteristic curve (AUROC) with 95% confidence intervals (CIs) derived from a 2000-resample patient-level bootstrap of out-of-fold classifications. Logistic regression coefficients were used to assess feature contributions. Results: For sepsis classification, the non-laboratory model achieved an AUPRC of 0.942 (95% CI: 0.884–0.979) and an AUROC of 0.945 (95% CI: 0.890–0.983), with comparable performance from the clinical + laboratory model (AUPRC 0.941, 95% CI: 0.880–0.981; AUROC 0.945, 95% CI: 0.881–0.986). For septic shock, AUROCs of 0.870 (95% CI: 0.761–0.952) and 0.878 (95% CI: 0.758–0.967) were observed. However, these estimates should be interpreted cautiously, given the low prevalence (23%) and absence of external validation. SpO2:FiO2 ratio, GCS, and systolic blood pressure were consistently strong predictors across models. Conclusions: ML models using pragmatic clinical variables demonstrate preliminary diagnostic performance, with the non-laboratory model showing discrimination comparable to models incorporating laboratory data. Logistic regression demonstrated the most stable performance and may represent an early proof of concept for assistive diagnostic support. However, these models are not clinically usable without external validation. These findings are hypothesis-generating; external validation in larger, independent cohorts is essential before any clinical use, particularly for septic shock.